Market Tracker

03/24 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

41.98
Delayed Data
As of Mar 24
 +0.48 / +1.16%
Today’s Change
33.56
Today|||52-Week Range
55.15
+8.48%
Year-to-Date

Today’s Trading

Previous close41.50
Today’s open41.65
Day’s range41.38 - 42.26
Volume462,606
Average volume (3 months)1,014,593
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-40.03%
Earnings growth (next 5 years)-32.75%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book11.58

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.15+1.32%
NKTRNektar Therapeutics-0.11-0.49%
TECHBio-Techne Corp+0.32+0.31%
KITEKite Pharma Inc+2.34+3.14%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
President, Chief Operating &
Financial Officer
David-Alexandre C. Gros
Corporate headquarters
San Diego, California

Forecasts